<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2005210740
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Poliza
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DONEPEZIL HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Dispersible tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        120.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="UNITED PHARMACEUTICAL COMPANY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            UNITED PHARMACEUTICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MS Pharma Saudi (MSPS)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06DA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Poliza contains the active substance donepezil hydrochloride. Donepezil</p><p>hydrochloride belongs to a group of medicines called acetylcholinesterase inhibitors.</p><p>Donepezil hydrochloride increases the levels of a substance (acetylcholine) in the brain</p><p>involved in memory function by slowing down the breakdown of that substance.</p><p>It is used to treat the symptoms of dementia in people diagnosed as having mild to moderately</p><p>severe Alzheimer&rsquo;s disease. Symptoms of the illness include increasing memory loss,</p><p>confusion and behavioural changes. As a result, sufferers of Alzheimer&rsquo;s disease find it more</p><p>difficult to carry out their normal daily activities.</p><p>It is for use in adult patients only.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Poliza </strong></p><p>- if you are allergic to donepezil, to piperidine derivative medicines (your doctor or</p><p>pharmacist can advise on this) or any of the other ingredients of this medicine (listed in</p><p>section 6).</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Poliza &nbsp;if you suffer, or</p><p>have ever suffered, from any of the following conditions:</p><p> Heart rate or rhythm problem (e.g. an irregular heart beat or other conditions that affect</p><p>the rate or rhythm of the heart)</p><p> Stomach or duodenal (gut) ulcers</p><p> Difficulty passing urine</p><p> Fits or seizures</p><p> Stiffness, shaking or uncontrollable movement especially of the face and tongue but</p><p>also of the limbs (which may have occurred after taking certain medicines and referred</p><p>to as &lsquo;extrapyramidal&rsquo; or &lsquo;Parkinson&rsquo;s&rsquo; like effects)</p><p> Asthma or other long-term lung problems</p><p> Liver problems.<br />&nbsp;</p><p><strong>Children and adolescents</strong></p><p>Children and adolescents under the age of 18 years of age should not take this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Poliza </strong></p><p>Please tell your doctor or pharmacist if you are taking, have recently taken or might take any</p><p>other medicines. In particular, tell your doctor or pharmacist if you are taking any of the</p><p>following:</p><p> Other Alzheimer&rsquo;s disease medicines, e.g. galantamine</p><p> Anticholinergics (medicines which typically cause dry mouth, blurred vision and/or</p><p>drowsiness) e.g. tolterodine (used for bladder problems)</p><p> Antidepressants (e.g. fluoxetine)</p><p> Erythromycin (an antibiotic)</p><p> Rifampicin (for treatment of tuberculosis)</p><p> Antifungal medicines e.g. ketoconazole, itraconazole</p><p> carbamazepine or phenytoin (for the control of epilepsy)</p><p> Medication for heart conditions e.g. quinidine, beta blockers (e.g. propranolol and</p><p>atenolol)</p><p> pain killers or treatment for arthritis e.g. acetylsalicylic acid (&lsquo;aspirin&rsquo;), non steroidal</p><p>anti-inflammatory drugs NSAID) such as ibuprofen or diclofenac</p><p> Muscle relaxants e.g. diazepam</p><p>If you are going to have an operation, including dental surgery, that requires you to have an</p><p>anaesthetic, tell your doctor, dentist, hospital staff or the anaesthetist that you are taking this</p><p>medicine.</p><p>&nbsp;</p><p><strong>Poliza &nbsp;with alcohol</strong></p><p>Take special care if drinking alcohol whilst taking this medicine, as alcohol can reduce the</p><p>effect of donepezil hydrochloride.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant, think you may be pregnant or planning to have a baby, do not take this</p><p>medicine before speaking to your doctor for advice. Poliza &nbsp;should not be</p><p>used in pregnancy unless clearly necessary.</p><p>Women taking this medicine should not breast-feed.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Do not drive or operate machinery if you feel dizzy, sleepy/tired or get muscle cramps while</p><p>taking this medicine.</p><p>Alzheimer&rsquo;s disease may also impair your ability to drive or operate machinery and you must</p><p>not perform these activities unless your doctor tells you that it is safe to do so.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your</p><p>doctor or pharmacist if you are not sure.</p><p>Tell the doctor the name of your caregiver. Your caregiver will help you take your medicine</p><p>as it is prescribed.</p><p><strong>Adults</strong></p><p>The recommended starting dose is 5 mg taken once a day, normally in the evening before you</p><p>go to bed, for at least one month.</p><p>After one month, your doctor may increase this to 10 mg taken once a day, normally in the</p><p>evening before you go to bed.</p><p>The maximum daily dose is 10 mg.</p><p>&nbsp;</p><p><strong>Use in patients with liver and kidney disease</strong></p><p>For adults with mild to moderate liver problems, your doctor may need to adjust your dose.</p><p>No dosage adjustment is normally required if you have kidney problems.</p><p>&nbsp;</p><p><strong>Use in children or adolescents</strong></p><p>Children and adolescents under the age of 18 years of age should not take this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Method of administration</strong></p><p>The tablet should be placed on your tongue and allowed to disintegrate before swallowing,</p><p>with or without water, according to your preference. You can take this medicine with or</p><p>without food.</p><p>Your doctor will advise you on how long you should continue to take your tablets. You will</p><p>need to see your doctor regularly to review your treatment and assess your symptoms.</p><p><strong>&nbsp;</strong></p><p><strong>If you take more Poliza &nbsp;than you should</strong></p><p>Do not take more than one tablet each day. Contact your doctor or nearest hospital casualty</p><p>department immediately if you take more tablets than you should. Take the container and any</p><p>remaining tablets with you to the hospital so that the doctor knows what has been taken.</p><p>Symptoms of taking more than you should include feeling and being sick, salivation,</p><p>sweating, slow heart rate, low blood pressure (light-headedness or dizziness when standing),</p><p>breathing problems, losing consciousness, seizures (fits) or convulsions and muscle weakness.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take Poliza </strong></p><p>If you forget to take a tablet, just take one tablet the following day at the usual time. Do not</p><p>take a double dose to make up for a forgotten tablet.</p><p>If you forget to take your medicine for more than one week, contact your doctor before taking</p><p>any more medicine.</p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking Poliza </strong></p><p>When treatment is stopped the beneficial effects of Poliza &nbsp;will decrease</p><p>gradually.</p><p>Do not stop taking your tablets without first discussing with your doctor.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Tell your doctor or go to your nearest hospital casualty department straight away if you</strong></p><p><strong>have any of the following serious side effects:</strong></p><p>Uncommon (may affect up to 1 in 100 people):</p><p> bleeding in the stomach, guts or bowel, or ulcers of the stomach or duodenum (gut). If</p><p>you are sick you may notice fresh blood or coffee like grounds in the sick, or you may</p><p>pass black tarry stools (poo) or fresh blood from the rectum (back passage)</p><p> Seizures (fits).</p><p>Rare (may affect up to 1 in 1,000 people):</p><p> Liver problems including hepatitis (inflammation of the liver). You may notice</p><p>dark urine, pale stools, yellowing of the skin and whites of the eyes (jaundice), you may</p><p>feel sick and have a fever)</p><p> changes in heart rhythm or a very slow heart rate.</p><p>Very rare (may affect up to 1 in 10,000 people):</p><p> Fever with muscle stiffness, sweating or a lowered level of consciousness (a disorder</p><p>called &quot;Neuroleptic Malignant Syndrome&quot;)</p><p> Muscle weakness, tenderness or pain and particularly, if at the same time, you feel</p><p>unwell, have a high temperature or have dark urine. They may be caused by an</p><p>abnormal muscle breakdown which can be life threatening and lead to kidney</p><p>problems (a condition called rhabdomyolysis).</p><p>Other side effects include:</p><p><strong>Very common (may </strong><strong>affect more than 1 in 10 people</strong><strong>):</strong></p><p> diarrhoea</p><p> feeling sick</p><p> headache.</p><p><strong>Common (</strong><strong>may affect up to 1 in 10 people)</strong><strong>:</strong></p><p> being sick</p><p> Muscle cramps</p><p> Feeling tired</p><p> Insomnia (difficulty in sleeping)</p><p> Common cold</p><p> Anorexia (loss of appetite)</p><p> Hallucinations (seeing or hearing things that are not really there)</p><p> Unusual dreams including nightmares</p><p> Agitation</p><p> Aggressive behaviour</p><p> fainting</p><p> feeling dizzy</p><p> Abdominal pain or discomfort</p><p> Skin rash and itching</p><p> passing urine uncontrollably</p><p> Pain</p><p> Accidents (patients may be more prone to falls and accidental injury).</p><p><strong>Uncommon (may affect up to </strong><strong>1 in 100 people)</strong><strong>:</strong></p><p> Slow heartbeat</p><p> an increase in the levels of a substance called creatine kinase in your blood which is</p><p>involved in metabolism, which may be seen in blood tests.</p><p><strong>Rare (</strong><strong>may affect up to 1 in 1,000 people</strong><strong>):</strong></p><p> Stiffness, shaking or uncontrollable movement especially of the face and tongue but</p><p>also of the limbs.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p> Keep this medicine out of the sight and reach of children.</p><p dir="RTL"> Do not store above 30&deg;C</p><p> Do not use this medicine after the expiry date, which is stated on the carton and</p><p>blister after EXP. The expiry date refers to the last day of that month.</p><p> Do not throw away any medicines via wastewater or household waste. Ask your</p><p>pharmacist how to throw away medicines you no longer use. These measures will</p><p>help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is donepezil hydrochloride.</p><p>- Poliza&nbsp; 5 mg Orodispersible Tablets: Each tablet contains 5 mg</p><p>donepezil hydrochloride (equivalent to 5.1 mg donepezil).</p><p>- Poliza &nbsp;10 mg Orodispersible Tablets: Each tablet contains 10 mg</p><p>donepezil hydrochloride (equivalent to 10.2 mg donepezil).</p><p>The other ingredients are mannitol; silica colloidal anhydrous;</p><p>crospovidone ,microcrystalline cellulose; magnesium stearate, Xvlitol,</p><p>Magnesium Aluminometasilicat and yellow iron oxide</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Your medicine is in the form of an orodispersible tablet.
Poliza 5 mg Orodispersible Tablets are yellow round biconvex tablets plain from both sides.
Poliza 10 mg Orodispersible Tablets are yellow coloured round flat shaped tablets scored on one side and plain on the other side , please note:” The score line on the tablet is a cosmetic line and not a functional score. The tablet is not intended to be divided. 
Poliza  5& 10 mg Orodispersible Tablets are packed in blister 30 ODT .

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>MS Pharma Saudi,</p><p>Riyadh, Kingdome Saudi Arabia.</p><p>info-ksa@mspharma.com</p><p>&nbsp;</p><p><strong>Manufacturer by:</strong></p><p>&nbsp;United Pharmaceutical Mfg. Co. Ltd. &ndash; Jordan for MS Pharma-Saudi.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Jan,2021	
SPM190503

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">المادة الفعالة التي يحتوي عليها الدواء: دونيبيزيل هيدروكلورايد. ينتمي هذا الدواء إلى مجموعة من الأدوية تُسمّى مثبطات إنزيم الأسيتيل كولين استيريز.</p><p dir="RTL">يعمل دونيبيزيل هيدروكلورايد على زيادة مستويات مادة الأسيتيل كولين في الدماغ التي تُساهم في وظائف الذاكرة وذلك عن طريق إبطاء تكسير هذه المادة.</p><p dir="RTL">يستخدم أيضا لعلاج أعراض الخرف (فقدان الذاكرة) لدى الأشخاص الذين تم تشخيصهم بأنهم مصابين بمرض ألزهايمر بدرجة خفيفة إلى معتدلة. تشمل أعراض المرض على زيادة في فقدان الذاكرة، وتشوش الذهن، وتغيرات سلوكية.</p><p dir="RTL">. ونتيجة لذلك؛ فإن المرضى المصابين بمرض ألزهامير يواجهون صعوبة بالغة في إتمام مهامهم اليومية الطبيعية.&nbsp;</p><p dir="RTL">يُستخدم هذا الدواء في المرضى البالغين فقط.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول <strong>بوليزا</strong> في الحالات الآتية:</p><p dir="RTL">&bull; إذا كانت لديك حساسية مفرطة لمادة دونيبيزيل أو المنتجات الدوائية المشتقة من مادة بيبريدين (يمكن أن ينصحك الطبيب أو الصيدلي بخصوص هذا الأمر) أو لأي مكونات أخرى في هذا الدواء (من المكونات المذكورة في الفقرة 6).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">يجب استشارة الطبيب أو الصيدلي قبل تناول هذا الدواء إذا كنت تعاني أو سبق وعانيت من أي من هذه الحالات التالية:</p><p dir="RTL">مشاكل في انتظام ضربات القلب أو اختلال إيقاع القلب (مثل: عدم انتظام في ضربات القلب أز حالات أخرى تؤثر على معدل ضربات القلب أو إيقاعه)</p><p dir="RTL">قرح في المعدة أو الإثني عشر (الأمعاء)</p><p dir="RTL">صعوبة في التبول</p><p dir="RTL">تشنجات أو نوبات صرعية</p><p dir="RTL">تيبّس، ارتجاف أو حركة لا إرادية خاصة في الوجه واللسان وقد تشمل الأطراف أيضا (والتي قد تحدث بعد تناول أدوية معينة حيث يُشار إلى ذلك بأنها تأثيرات مشابهة لمرض باركنسون أو لأعراض إصابة الألياف العصبية الخارجة عن المسار الهرمي)</p><p dir="RTL">الربو الشعبي أو مشاكل طويلة الأمد في الرئة</p><p dir="RTL">مشاكل في الكبد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقين</strong></p><p dir="RTL">يحذر تناول الأطفال والمراهقين الأصغر من 18 عاما لهذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أدوية أخرى مع بوليزا</strong></p><p dir="RTL">يجب عليك إخبار الطبيب أو الصيدليّ إذا كنت تتناول أدوية أو تناولت مؤخرًا بعض الأدوية أو تنوي تناول أي دواء آخر. وعلى وجه التحديد؛ يجب إخبار الطبيب أو الصيدليّ إذا كنت تتناول أي من هذه الأدوية الآتي ذكرها:</p><p dir="RTL">أدوية أخرى لعلاج مرض ألزهايمر، مثل جلانتامين.</p><p dir="RTL">الأدوية المضادة لإفراز الكولين (الأدوية التي تسبب جفاف الفم، تشوش الرؤية و / أو دُوخة) مثل تولتيرودين (المُستخدم في علاج مشاكل المثانة)</p><p dir="RTL">الأدوية المضادة للاكتئاب (مثل: فلوكزيتين)</p><p dir="RTL">إريثرومايسن (مضاد حيوي)</p><p dir="RTL">ريفامبسين (المستخدم في علاج مرض الدرن)</p><p dir="RTL">الأدوية المضادة للفطريات مثل كيتوكونازول، إيتراكونازول.</p><p dir="RTL">كاربامازيبين أو فينيتوين (المستخدم في التحكم في نوبات الصرع).</p><p dir="RTL">الأدوية المستخدمة في علاج مشاكل القلب مثل كوينيدين، حاصرات مستقبلات بيتا (مثل بروبرانولول، أتينالول)</p><p dir="RTL">مسكنات الألم أو الأدوية التي تعالج التهاب المفاصل مثل حمض السالسيليك (أسبرين)، الأدوية غير الستيرودية المضادة للالتهابات مثل إيبيبروفين، دايكلوفينك.</p><p dir="RTL">الأدوية الباسطة للعضلات مثل ديازبام.</p><p dir="RTL">إذا كنت ستخضع لإجراء عملية جراحية بما في ذلك عمليات الأسنان التي تطلب التخدير، فيجب حينها أن تخبر الطبيب أو طبيب الأسنان أو طاقم المستشفى أو طبيب التخدير أنك تتناول هذا الدواء. &nbsp;&nbsp;</p><p dir="RTL"><strong>تناول بوليزا مع المشروبات الكحولية</strong></p><p dir="RTL">يرجى توخي الحذر إذا كنت تتناول مشروبات كحولية أثناء تناولك لهذا الدواء، وذلك لأن الكحول يمكن أن يقلل من تأثير هذا الدواء.</p><p dir="RTL">الحمل والرضاعة الطبيعية</p><p dir="RTL">يجب استشارة الطبيب قبل تناول هذا الدواء في حالة السيدات الحوامل أو في حالات الاعتقاد بالحمل أو التخطيط لحدوث الحمل. يجب عدم استخدام هذا الدواء أثناء الحمل إلا إذا رأى الطبيب ضرورة ذلك.</p><p dir="RTL">يجب تجنب الرضاعة الطبيعية أثناء تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">يجب عليك تجنب القيادة واستخدام الآلات إذا شعرت بالدوار / التعب أو تقلصات في العضلات أثناء تناولك هذا الدواء.</p><p dir="RTL">قد يؤدي مرض ألزهايمر إلى إضعاف القدرة على القيادة أو تشغيل الآلات، لذلك يجب ألا تقوم بهذه الأنشطة إلا إذا أخبرك الطبيب بأنه من الآمن القيام بذلك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك تناول هذا الدواء وفقًا لتعليمات الطبيب. يرجى التوجه بالسؤال للطبيب أو الصيدلي في حالة عدم تأكدك.</p><p dir="RTL">أخبر الطبيب باسم مقدم الرعاية الخاص بك. سيساعدك الشخص المسؤول عن رعايتك في تناول الدواء كما تم وصفه لك من قبل الطبيب.</p><p dir="RTL"><strong>البالغين</strong></p><p dir="RTL">الجرعة الابتدائية هي 5 ملغم تؤخذ مرة في اليوم، عادة في المساء قبل النوم لمدة لا تقل عن شهر.</p><p dir="RTL">وبعد مرور شهر؛ قد يقوم الطبيب بزيادة جرعة الدواء إلى 10 ملغم تؤخذ مرة في اليوم، عادة في المساء قبل النوم.</p><p dir="RTL">أقصى جرعة يمكن تناولها في اليوم الواحد هي 10 ملغم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>استخدام هذا الدواء في مرضى الكبد والكلى</strong></p><p dir="RTL">قد يحتاج الطبيب لتعديل جرعة الدواء في المرضى البالغين الذين يعانون من مشاكل بسيطة إلى متوسطة الشدة في الكبد.</p><p dir="RTL">لا حاجة إلى تعديل جرعة الدواء - في الظروف العادية - إذا كنت تعاني من مشاكل في الكلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>استخدام الدواء مع الأطفال والمراهقين</strong></p><p dir="RTL">يحذر تناول الأطفال والمراهقين الأصغر من 18 عاما لهذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية تتناول هذا الدواء</strong></p><p dir="RTL">يجب وضع القرص على اللسان والسماح له بالتفكك قبل البلع، ويمكن تناوله مع أو بدون الماء، وفقًا لتفضيلك الشخصي. يمكنك تناول بوليزا مع الطعام أو بدونه.</p><p dir="RTL">سوف ينصحك الطبيب بشأن المدة التي يجب أن تستمر فيها على تناول هذا الدواء. ينبغي عليك رؤية الطبيب بانتظام من أجل مراجعة العلاج وتقييم الأعراض التي لديك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت جرعات من دواء بوليزا أكثر من الموصى بها</strong></p><p dir="RTL">لا تتناول أكثر من جرعة واحدة في اليوم. يجب استشارة الطبيب أو التوجه الفوري لقسم الطوارئ في أقرب مستشفى لك، إذا تناولت جرعة أكبر من الموصى بها.&nbsp;&nbsp; اصطحب معك إلى المستشفى عبوة الدواء والأقراص المتبقية منه من أجل يطّلع الطبيب عليها.</p><p dir="RTL">تشمل أعراض تناول جرعة أكثر من الموصى بها على الآتي: الشعور بالإرهاق، التعب، زيادة اللعاب، زيادة العرق، بطء سرعة ضربات القلب، انخفاض ضغط الدم (الدوار أو الدوخة عند الوقوف)، مشاكل في التنفس، فقدان الوعي، نوبات صرعية (تشنجات)، ضعف في العضلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت تناول الدواء</strong></p><p dir="RTL">إذا نسيت تناول جرعتك من الدواء، فلا يمكنك سوى تناول جرعتك المعتادة (قرص واحد) في اليوم التالي.&nbsp; لا تتناول جرعة مزدوجة لتعويض جرعتك الفائتة.</p><p dir="RTL">إذا نسيت تناول هذا الدواء لأكثر من أسبوع، فيجب عليك استشارة الطبيب أولا قبل البدء في تناول المزيد من الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول الدواء</strong></p><p dir="RTL">إذا تم إيقاف العلاج بدواء بوليزا فإن تأثيرات هذا الدواء ستقل تدريجيا.</p><p dir="RTL">لا تتوقف عن تناول هذا الدواء إلا بعد مناقشة ذلك مع الطبيب.</p><p dir="RTL">يرجى استشارة الطبيب أو الصيدلي إذا كانت لديك أية أسئلة إضافية فيما يتعلق بتناول هذا الدواء.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل كافة الأدوية، فإن هذا الدواء يمكن أن يتسبب في ظهور بعض الأعراض الجانبية، وعلى الرغم من ذلك فإنها لا تظهر على جميع المرضى.</p><p dir="RTL"><strong>يجب استشارة الطبيب أو التوجه الفوري لقسم الطوارئ في أقرب مشفى لك، إذا عانيت من أي من هذه الأعراض الجانبية الخطيرة: </strong></p><p dir="RTL"><strong>الأعراض الجانبية غير المألوفة (تؤثر في أقل من 1 بين 100 شخص):</strong></p><p dir="RTL">نزيف من المعدة، الأمعاء أو قرحة في المعدة أو في الإثني عشر (الأمعاء). يمكن أثناء شعورك بالتعب أن تلاحظ بأن القيء له لون دموي أو يشبه القهوة أو يمكن أن يكون البراز باللون الأسود أو أن تلاحظ خروج دم من المستقيم.</p><p dir="RTL">نوبات صرعية (تشنجات)</p><p dir="RTL"><strong>الأعراض الجانبية النادرة (تؤثر في 1 من بين 1,000 شخص):</strong></p><p dir="RTL">مشاكل في الكبد بما في ذلك التهاب الكبد (التهاب في نسيج الكبد) قد تلاحظ تحول البول إلى لون غامق، واصفرار الجلد وبياض العينين (يرقان)، كما يمكن أن تشعر التعب وتعاني من ارتفاع في درجة الحرارة.</p><p dir="RTL">تغيرات في إيقاع ضربات القلب أو بطء سرعة القلب.</p><p dir="RTL"><strong>الأعراض الجانبية النادرة جدا (تؤثر في أقل من 1 من بين 10,000 شخص):</strong></p><p dir="RTL">ارتفاع درجة الحرارة مع تيبس العضلات والعرق أو نقص مستوى الوعي (متلازمة مرضية تُدعى &quot;متلازمة مضادات الذهان الخبيثة&quot;)ضعف في العضلات، إيلام وألم في العضلات وخاصة إذا كنت في نفس وقت الشعور بالتعب تعاني من ارتفاع في درجة الحرارة أو تحول لون البول إلى لون غامق.&nbsp; قد يكون ذلك بسبب تكسر غير طبيعي للعضلات حيث يمكن أن يشكل ذلك خطرا على الحياة ويؤدي إلى مشاكل في الكلية (حالة تسمى انحلال الربيدات / العضلات).</p><p dir="RTL">أعراض جانبية أخرى:</p><p dir="RTL"><strong>الأعراض الجانبية المألوفة جدا (تؤثر في أكثر من 1 بين 10 أشخاص):</strong></p><p dir="RTL">إسهال</p><p dir="RTL">الشعور بالتعب</p><p dir="RTL">صداع</p><p dir="RTL"><strong>الأعراض الجانبية المألوفة (تؤثر في 1 من بين 10 أشخاص):</strong></p><p dir="RTL">التعب</p><p dir="RTL">تقلصات في العضلات</p><p dir="RTL">الشعور بالإرهاق</p><p dir="RTL">الأرق (صعوبة النوم)</p><p dir="RTL">الزكام (الرشح)</p><p dir="RTL">فقدان الشهية</p><p dir="RTL">الهلوسة (رؤية وسماع أشياء لا وجود لها في الواقع)</p><p dir="RTL">أحلام غير طبيعية بما في ذلك الكوابيس</p><p dir="RTL">التهيج العصبي</p><p dir="RTL">سلوك عدواني</p><p dir="RTL">الإغماء</p><p dir="RTL">الشعور الدوار</p><p dir="RTL">ألم في البطن أو عدم راحة</p><p dir="RTL">الطفح الجلدي. والحكة</p><p dir="RTL">التبول اللا إرادي</p><p dir="RTL">الشعور بالألم</p><p dir="RTL">التعرض للحوادث (قد يكون المريض أكثر عرضة للسقوط والتعرض للإصابات)</p><p dir="RTL"><strong>الأعراض الجانبية غير المألوفة (تؤثر في أقل من 1 بين 100 شخص):</strong></p><p dir="RTL">بطء في سرعة ضربات القلب</p><p dir="RTL">زيادة مستوى مادة الكرياتين كاينيز في الجسم والتي تنتج من العملية الأيضية، ويظهر ذلك في فحوصات الدم.</p><p dir="RTL"><strong>الأعراض الجانبية النادرة (تؤثر في 1 من بين 1,000 شخص):</strong></p><p dir="RTL">تيبّس، ارتجاف أو حركة لا إرادية خاصة في الوجه واللسان وقد تشمل الأطراف أيضا.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL">يحفظ في درجة حرارة لاتتجاوز 30 م&deg;</p><p dir="RTL">لا تستخدم الدواء بعد مرور تاريخ انتهاء الصلاحية الموضح على شريط الأقراص وعلى العبوة بعد كلمة EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير في الشهر.</p><p dir="RTL">لا تقم بإلقاء أية أدوية في مياه الصرف أو في النفايات المنزلية. وبدلاً عن ذلك قم باستشارة الصيدلي عن كيفية التخلص الآمن من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في المحافظة على البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- المادة الفعالة: دونيبيزيل هيدروكلورايد</p><p dir="RTL">أقراص <strong>بوليزا</strong> 5 ملغم تتفتت فمويًا: يحتوي كل قرص على 5 ملغم من دونيبيزيل هيدروكلورايد (ما يكافئ 5.1 ملغم من مادة دونيبيزيل).</p><p dir="RTL">أقراص <strong>بوليزا</strong> 10 ملغم تتفتت فمويًا: يحتوي كل قرص على 10 ملغم من دونيبيزيل هيدروكلورايد (ما يكافئ 10.2 ملغم من مادة دونيبيزيل).</p><p dir="RTL">باقي المكونات: مانيتول ، السيليكا الغروية اللامائية، كروسبوفايدون ، سليلوز دقيق البلورات، استيارات الماغنيسيوم ، إكسيليتول ، ماغنيسيوم سليكات الألمنيوم وأكسيد الحديد الأصفر.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يأتي هذا الدواء في صورة أقراص تتفتت فمويًا:.</p><p dir="RTL">أقراص <strong>بوليزا</strong> 5 ملغم تتفتت فمويًا لونها أصفر محدب الجانبين</p><p dir="RTL">أقراص <strong>بوليزا</strong> 10 ملغم تتفتت فمويًا لونها أصفر ولها سطح دائري الشكل منصَفة من جانب ومسطحة من الجانب الآخر</p><p dir="RTL">يرجى ملاحظة ما يلي: &quot; الخط الموجود على قرص الدواء عبارة عن خط تجميلي وليس لأجل تقسيم القرص&quot;</p><p dir="RTL">تتوفر <strong>بوليزا</strong> 5 ملغم و10ملغم&nbsp; كأقراص تتفتت فمويًا في شرائط 30 حبة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إم إس فارما السعودية</p><p>الرياض ، المملكة العربية السعودية .</p><p dir="RTL">&nbsp;&nbsp; info-ksa@mspharma.com</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>صنعت بواسطة </strong><strong>:</strong></p><p dir="RTL">المتحدة للصناعات الدوائية - الأردن <strong>لصالح </strong>إم إس فارما &ndash; المملكة العربية السعودية</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يناير،2021
SPM190503

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Poliza 5 mg Orodispersible Tablets
Poliza 10 mg Orodispersible Tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 10 mg tablet contains 5 mg donepezil hydrochloride (as monohydrate), equivalent to 5.1mg of donepezil free base.
Each 10 mg tablet contains 10 mg donepezil hydrochloride (as monohydrate), equivalent to 10.2mg of donepezil free base.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Orodispersible tablet
Poliza 5mg Orodispersible Tablets are Yellow round biconvex tablets plain from both sides.
Poliza 10mg Orodispersible Tablets are yellow coloured round flat shaped tablets scored on one side and plain on the other side. please note:” The score line on the tablet is a cosmetic line and not a functional score. The tablet is not intended to be divided.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Poliza is indicated for the symptomatic treatment of mild to moderately severe Alzheimer&#39;s dementia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><strong><em>Adults/Elderly</em></strong></p><p>Treatment is initiated at 5 mg/day (once-a-day dosing).</p><p>The 5 mg/day dose should be maintained for at least one month in order to allow the earliest clinical responses to treatment to be assessed and to allow steady-state concentrations of Poliza to be achieved.</p><p>Following a one-month clinical assessment of treatment at 5 mg/day, the dose of Poliza can be increased to 10 mg/day (once-a-day dosing). The maximum recommended daily dose is 10 mg. Doses greater than 10 mg/day have not been studied in clinical trials.</p><p>Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer&#39;s dementia. Diagnosis should be made according to accepted guidelines (e.g. DSM IV, ICD 10).</p><p>Therapy with Poliza should only be started if a caregiver is available who will regularly monitor drug intake for the patient.</p><p>Maintenance treatment can be continued for as long as a therapeutic benefit for the patient exists. Therefore, the clinical benefit of Poliza should be reassessed on a regular basis.</p><p>Discontinuation should be considered when evidence of a therapeutic effect is no longer present. Individual response to Poliza cannot be predicted.</p><p>Upon discontinuation of treatment, a gradual abatement of the beneficial effects of Poliza is seen.</p><p><strong><em>Patients with renal or hepatic impairment</em></strong></p><p>A similar dose schedule can be followed for patients with renal impairment, as clearance of Poliza is not affected by this condition.</p><p>Due to possible increased exposure in mild to moderate hepatic impairment (see section 5.2), dose escalation should be performed according to individual tolerability. There are no data for patients with severe hepatic impairment.</p><p><strong><em>Paediatric population</em></strong></p><p>Poliza is not recommended for use in children.</p><p><u>Method of administration</u></p><p>For oral use.</p><p>Poliza should be taken orally, in the evening, just prior to retiring.</p><p>The tablet should be placed on the tongue and allowed to disintegrate before swallowing with or without water, according to patient preference.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, piperidine derivatives or to any excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The use of Poliza in patients with severe dementia, other types of dementia or other types of memory impairment (e.g. age-related cognitive decline), has not been investigated.</p><p><strong>Anaesthesia</strong></p><p>Poliza, as a cholinesterase inhibitor, is likely to exaggerate succinylcholine-type muscle relaxation during anaesthesia.</p><p><strong>Cardiovascular conditions</strong></p><p>Because of their pharmacological action, cholinesterase inhibitors may have vagotonic effects on heart rate (e.g., bradycardia). The potential for this action may be particularly important to patients with &quot;sick sinus syndrome&quot; or other supraventricular cardiac conduction conditions, such as sinoatrial or atrioventricular block.</p><p>There have been reports of syncope and seizures. In investigating such patients the possibility of heart block or long sinusal pauses should be considered.</p><p><strong>Gastrointestinal conditions:</strong></p><p>Patients at increased risk for developing ulcers, e.g., those with a history of ulcer disease or those receiving concurrent nonsteroidal anti-inflammatory drugs (NSAIDs), should be monitored for symptoms. However, the clinical studies with donepezil showed no increase, relative to placebo, in the incidence of either peptic ulcer disease or gastrointestinal bleeding.</p><p><strong>Genitourinary</strong></p><p>Although not observed in clinical trials of donepezil, cholinomimetics may cause bladder outflow obstruction.</p><p><strong>Neurological conditions</strong></p><p>Seizures: Cholinomimetics are believed to have some potential to cause generalised convulsions. However, seizure activity may also be a manifestation of Alzheimer&#39;s disease.</p><p>Cholinomimetics may have the potential to exacerbate or induce extrapyramidal symptoms.</p><p>Neuroleptic Malignant Syndrome (NMS): NMS, a potentially life-threatening condition characterised by hyperthermia, muscle rigidity, autonomic instability, altered consciousness and elevated serum creatine phosphokinase levels, has been reported to occur very rarely in association with donepezil, particularly in patients also receiving concomitant antipsychotics. Additional signs may include myoglobinuria (rhabdomyolysis) and acute renal failure. If a patient develops signs and symptoms indicative of NMS, or presents with unexplained high fever without additional clinical manifestations of NMS, treatment should be discontinued.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Pulmonary conditions</strong></p><p>Because of their cholinomimetic actions, cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease.</p><p>The administration of Poliza concomitantly with other inhibitors of acetylcholinesterase, agonists or antagonists of the cholinergic system should be avoided.</p><p><strong>Severe hepatic impairment</strong></p><p>There are no data for patients with severe hepatic impairment.</p><p><strong>Mortality in vascular dementia clinical trials</strong></p><p>Three clinical trials of 6 months duration were conducted studying individuals meeting the NINDS-AIREN criteria for probable or possible vascular dementia (VaD). The NINDS-AIREN criteria are designed to identify patients whose dementia appears to be due solely to vascular causes and to exclude patients with Alzheimer&#39;s disease. In the first study, the mortality rates were 2/198 (1.0%) on Poliza 5 mg, 5/206 (2.4%) on Poliza 10 mg and 7/199 (3.5%) on placebo. In the second study, the mortality rates were 4/208 (1.9%) on Poliza 5 mg, 3/215 (1.4%) on Poliza 10 mg and 1/193 (0.5%) on placebo. In the third study, the mortality rates were 11/648 (1.7%) on Poliza 5 mg and 0/326 (0%) on placebo. The mortality rate for the three VaD studies combined in the donepezil hydrochloride group (1.7%) was numerically higher than in the placebo group (1.1%), however, this difference was not statistically significant. The majority of deaths in patients taking either Poliza or placebo appear to result from various vascular related causes, which could be expected in this elderly population with underlying vascular disease. An analysis of all serious non-fatal and fatal vascular events showed no difference in the rate of occurrence in the donepezil hydrochloride group relative to placebo.</p><p>In pooled Alzheimer&#39;s disease studies (n=4146), and when these Alzheimer&#39;s disease studies were pooled with other dementia studies including the vascular dementia studies (total n=6888), the mortality rate in the placebo groups numerically exceeded that in the donepezil hydrochloride groups.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Donepezil hydrochloride and/or any of its metabolites do not inhibit the metabolism of theophylline, warfarin, cimetidine or digoxin in humans. The metabolism of donepezil hydrochloride is not affected by concurrent administration of digoxin or cimetidine.</p><p><em>In vitro</em>&nbsp;studies have shown that the cytochrome P450 isoenzymes 3A4 and to a minor extent 2D6 are involved in the metabolism of donepezil. Drug interaction studies performed&nbsp;<em>in vitro</em>&nbsp;show that ketoconazole and quinidine, inhibitors of CYP3A4 and 2D6 respectively, inhibit donepezil metabolism. Therefore these and other CYP3A4 inhibitors, such as itraconazole and erythromycin, and CYP2D6 inhibitors, such as fluoxetine, could inhibit the metabolism of donepezil.</p><p>In a study in healthy volunteers, ketoconazole increased mean donepezil concentrations by about 30%.</p><p>Enzyme inducers, such as rifampicin, phenytoin, carbamazepine and alcohol may reduce the levels of donepezil.</p><p>Since the magnitude of an inhibiting or inducing effect is unknown, such drug combinations should be used with care.</p><p>Poliza has the potential to interfere with medications having anticholinergic activity. There is also the potential for synergistic activity with concomitant treatment involving medications such as succinylcholine, other neuro-muscular blocking agents or cholinergic agonists or beta blocking agents that have effects on cardiac conduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Pregnancy</em></strong></p><p>There are no adequate data from the use of Poliza in pregnant women.</p><p>Studies in animals have not shown teratogenic effect but have shown peri and post natal toxicity (see section 5.3). The potential risk for humans is unknown.</p><p>Poliza should not be used during pregnancy unless clearly necessary.</p><p><strong><em>Breast-feeding</em></strong></p><p>Poliza is excreted in the milk of rats. It is not known whether Poliza is excreted in human breast milk and there are no studies in lactating women. Therefore, women on Poliza should not breast feed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Poliza has minor or moderate influence on the ability to drive and use machines.</p><p>Dementia may cause impairment of driving performance or compromise the ability to use machinery. Furthermore, Poliza can induce fatigue, dizziness and muscle cramps, mainly when initiating or increasing the dose. The treating physician should routinely evaluate the ability of patients on Poliza to continue driving or operating complex machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most common adverse events are diarrhoea, muscle cramps, fatigue, nausea, vomiting and insomnia.</p><p>Adverse reactions reported as more than an isolated case are listed below, by system organ class and by frequency. Frequencies are defined as: very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100) rare (&ge; 1/10,000 to &lt;1/1,000); very rare (&lt;1/10000) and not known (cannot be estimated from available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Very Common</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td><td style="vertical-align:top"><p><strong>Very Rare</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Common cold</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Hallucinations**</p><p>Agitation **</p><p>Aggressive behaviour**</p><p>Abnormal dreams and Nightmares**</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Syncope*</p><p>Dizziness</p><p>Insomnia</p></td><td style="vertical-align:top"><p>Seizure*</p></td><td style="vertical-align:top"><p>Extrapyramidal symptoms</p></td><td style="vertical-align:top"><p>Neuroleptic Malignant Syndrome</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Bradycardia</p></td><td style="vertical-align:top"><p>Sino-atrial block</p><p>Atrioventricular block</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Diarrhoea</p><p>Nausea</p></td><td style="vertical-align:top"><p>Vomiting</p><p>Abdominal disturbance</p></td><td style="vertical-align:top"><p>Gastrointestinal haemorrhage</p><p>Gastric and duodenal ulcers</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Liver dysfunction including hepatitis***</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash</p><p>Pruritis</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Muscle cramps</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rhabdomyolysis****</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Urinary incontinence</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Fatigue</p><p>Pain</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Minor increase in serum concentration of muscle creatine kinase</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Injury, poisoning and procedural complications</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Accident</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr></tbody></table><p>* In investigating patients for syncope or seizure the possibility of heart block or long sinusal pauses should be considered (see section 4.4)</p><p>** Reports of hallucinations, abnormal dreams, nightmares, agitation and aggressive behaviour have resolved on dose-reduction or discontinuation of treatment.</p><p>*** In cases of unexplained liver dysfunction, withdrawal of Poliza should be considered.</p><p>**** Rhabdomyolysis has been reported to occur independently of neuroleptic malignant syndrome and in close temporal association with donepezil initiation or dose increase.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>To reports any side effect(s):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p dir="RTL"><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_2" o:spid="_x0000_s1026"
 type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
 margin-left:.75pt;margin-top:6.05pt;width:375.05pt;height:96pt;z-index:251659264;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:3.6pt;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:3.6pt;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal style='text-align:left;mso-layout-grid-align:none;
    text-autospace:none;direction:ltr;unicode-bidi:embed'><span
    style='font-family:"TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'>-
    The National Pharmacovigilance and Drug Safety Centre (NPC) :<o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpFirst style='margin-bottom:10.0pt;mso-add-space:
    auto;text-indent:-18.0pt;line-height:115%;mso-list:l2 level1 lfo1;
    mso-layout-grid-align:none;text-autospace:none'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'>Fax:
    +966-11-205-7662<o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpMiddle style='margin-bottom:10.0pt;mso-add-space:
    auto;text-indent:-18.0pt;line-height:115%;mso-list:l2 level1 lfo1;
    mso-layout-grid-align:none;text-autospace:none'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'>SFDA Call
    Center: 19999<o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpMiddle style='margin-bottom:10.0pt;mso-add-space:
    auto;text-indent:-18.0pt;line-height:115%;mso-list:l2 level1 lfo1;
    mso-layout-grid-align:none;text-autospace:none'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'>E-mail: </span><a
    href="mailto:npc.drug@sfda.gov.sa"><span style='font-family:"TimesNewRomanPSMT",serif;
    mso-bidi-font-family:TimesNewRomanPSMT'>npc.drug@sfda.gov.sa</span></a><span
    style='font-family:"TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'><o:p></o:p></span></p>
    <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt;mso-list:l2 level1 lfo1'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-family:
    "TimesNewRomanPSMT",serif;mso-bidi-font-family:TimesNewRomanPSMT'>Website: https://ade.sfda.gov.sa<o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-indent:-18.0pt'><span dir=LTR><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="square"/>
</v:shape><![endif]--><img width="506" height="134" alt="Text Box: - The National Pharmacovigilance and Drug Safety Centre (NPC) :
•	Fax: +966-11-205-7662
•	SFDA Call Center: 19999
•	E-mail: npc.drug@sfda.gov.sa
•	Website: https://ade.sfda.gov.sa

" src="file:///C:/Users/ABDUAL~1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Poliza is a specific reversible acetylcholinesterase inhibitor.</p><p>The estimated median lethal dose of Poliza following administration of a single oral dose in mice and rats is 45 and 32 mg/kg, respectively, or approximately 225 and 160 times the maximum recommended human dose of 10 mg per day. Dose-related signs of cholinergic stimulation were observed in animals and included reduced spontaneous movement, prone position, staggering gait, lacrimation, clonic convulsions, depressed respiration, salivation, miosis, fasciculation and lower body surface temperature.</p><p>Overdosage with cholinesterase inhibitors can result in cholinergic crisis characterised by severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, respiratory depression, collapse and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved.</p><p>As in any case of overdose, general supportive measures should be utilised.</p><p>Tertiary anticholinergics such as atropine may be used as an antidote for Poliza overdosage. Intravenous atropine sulphate titrated to effect is recommended: an initial dose of 1.0 to 2.0 mg IV with subsequent doses based upon clinical response.</p><p>Atypical responses in blood pressure and heart rate have been reported with other cholinomimetics when co-administered with quaternary anticholinergics such as glycopyrrolate.</p><p>It is not known whether Poliza and/or its metabolites can be removed by dialysis (haemodialysis, peritoneal dialysis, or haemofiltration).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: anti-dementia drugs; anticholinesterases, ATC code: N06DA02.</p><p>Poliza is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain. Poliza is&nbsp;<em>in vitro</em>&nbsp;over 1000 times more potent an inhibitor of this enzyme than of butyrylcholinesterase, an enzyme which is present mainly outside the central nervous system.</p><p><u>Alzheimer&#39;s Dementia</u></p><p>In patients with Alzheimer&#39;s Dementia participating in clinical trials, administration of single daily doses of 5 mg or 10 mg of Poliza produced steady-state inhibition of acetylcholinesterase activity (measured in erythrocyte membranes) of 63.6% and 77.3%, respectively when measured post dose. The inhibition of acetylcholinesterase (AChE) in red blood cells by Poliza has been shown to correlate to changes in ADAS-cog, a sensitive scale which examines selected aspects of cognition.</p><p>The potential for Poliza to alter the course of the underlying neuropathology has not been studied. Thus Poliza cannot be considered to have any effect on the progress of the disease.</p><p>Efficacy of treatment of Alzheimer&#39;s Dementia with Poliza has been investigated in four placebo-controlled trials, 2 trials of 6-month duration and 2 trials of 1-year duration.</p><p>In the 6 months clinical trial, an analysis was done at the conclusion of Poliza treatment using a combination of three efficacy criteria: the ADAS-Cog (a measure of cognitive performance), the Clinician Interview Based Impression of Change with Caregiver Input (a measure of global function) and the Activities of Daily Living Subscale of the Clinical Dementia Rating Scale (a measure of capabilities in community affairs, home and hobbies and personal care).</p><p>Patients who fulfilled the criteria listed below were considered treatment responders.</p><p>Response = Improvement of ADAS-Cog of at least 4 points.</p><p>No deterioration of CIBIC</p><p>No deterioration of Activities of Daily Living Schedule of the Clinical Dementia Rating Scale.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td rowspan="2" style="vertical-align:top">&nbsp;</td><td colspan="2" style="vertical-align:top"><p>% response</p></td></tr><tr><td style="vertical-align:top"><p>Intent to treat population</p><p>n = 365</p></td><td style="vertical-align:top"><p>Evaluable population</p><p>n = 352</p></td></tr><tr><td style="vertical-align:top"><p>Placebo group</p></td><td style="vertical-align:top"><p>10%</p></td><td style="vertical-align:top"><p>10%</p></td></tr><tr><td style="vertical-align:top"><p>Donepezil 5 mg group</p></td><td style="vertical-align:top"><p>18%*</p></td><td style="vertical-align:top"><p>18%*</p></td></tr><tr><td style="vertical-align:top"><p>Donepezil 10 mg group</p></td><td style="vertical-align:top"><p>21%*</p></td><td style="vertical-align:top"><p>22%**</p></td></tr></tbody></table><p>* p&lt;0.05</p><p>** p&lt;0.01</p><p>Poliza produced a dose-dependent statistically significant increase in the percentage of patients who were judged treatment responders.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Maximum plasma levels are reached approximately 3 to 4 hours after oral administration. Plasma concentrations and area under the curve rise in proportion to the dose. The terminal disposition half-life is approximately 70 hours, thus, administration of multiple single-daily doses results in gradual approach to steady-state. Approximate steady-state is achieved within 3 weeks after initiation of therapy. Once at steady-state, plasma Poliza concentrations and the related pharmacodynamic activity show little variability over the course of the day.</p><p>Food did not affect the absorption of Poliza.</p><p><strong>Distribution</strong></p><p>Poliza is approximately 95% bound to human plasma proteins. The plasma protein binding of the active metabolite 6-O-desmethyldonepezil is not known.</p><p>The distribution of Poliza in various body tissues has not been definitively studied.</p><p>However, in a mass balance study conducted in healthy male volunteers, 240 hours after the administration of a single 5 mg dose of 14C-labelled Poliza, approximately 28% of the label remained unrecovered. This suggests that Poliza and/or its metabolites may persist in the body for more than 10 days.</p><p><strong>Biotransformation/Elimination</strong></p><p>Poliza is both excreted in the urine intact and metabolised by the cytochrome P450 system to multiple metabolites, not all of which have been identified.</p><p>Following administration of a single 5 mg dose of&nbsp;<sup>14</sup>C-labelled Poliza, plasma radioactivity, expressed as a percent of the administered dose, was present primarily as intact Poliza (30%), 6-O-desmethyldonepezil (11% - only metabolite that exhibits activity similar to Poliza), donepezil-cis-N-oxide (9%), 5-O-desmethyldonepezil (7%) and the glucuronide conjugate of 5-O-desmethyl-donepezil (3%).</p><p>Approximately 57% of the total administered radioactivity was recovered from the urine (17% as unchanged donepezil), and 14.5% was recovered from the faeces, suggesting biotransformation and urinary excretion as the primary routes of elimination. There is no evidence to suggest enterohepatic recirculation of Poliza and/or any of its metabolites.</p><p>Plasma Poliza concentrations decline with a half-life of approximately 70 hours.</p><p>Sex, race and smoking history have no clinically significant influence on plasma concentrations of Poliza. The pharmacokinetics of donepezil has not been formally studied in healthy elderly subjects or in Alzheimer&#39;s or vascular dementia patients. However mean plasma levels in patients closely agreed with those of young healthy volunteers.</p><p>Patients with mild to moderate hepatic impairment had increased donepezil steady state concentrations; mean AUC by 48% and mean C<sub>max</sub>&nbsp;by 39% (see section 4.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Extensive testing in experimental animals has demonstrated that this compound causes few effects other than the intended pharmacological effects consistent with its action as a cholinergic stimulator (see section 4.9). Donepezil is not mutagenic in bacterial and mammalian cell mutation assays. Some clastogenic effects were observed&nbsp;<em>in vitro&nbsp;</em>at concentrations overtly toxic to the cells and more than 3000 times the steady-state plasma concentrations. No clastogenic or other genotoxic effects were observed in the mouse micronucleus model&nbsp;<em>in vivo</em>. There was no evidence of oncogenic potential in long term carcinogenicity studies in either rats or mice.</p><p>Poliza had no effect on fertility in rats, and was not teratogenic in rats or rabbits, but had a slight effect on still-births and early pup survival when administered to pregnant rats at 50 times the human dose (see section 4.6).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Silicon Colloidal Dioxide</p><p>Magnesium stearate</p><p>Yellow iron oxide</p><p><strong>F-Melt type M :</strong></p><p>D-Mannitol</p><p>Xvlitol</p><p>Cellulose, microcrystalline</p><p>Crospovidone</p><p>Magnesium Aluminometasilicat</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Packed in PVC/TE/PVDC/AL blister and leaflet then</p><p>packed in cardboard cartons.</p><p>One cartoon pack contains one Aluminium/aluminium blisters : 30 orodispersible tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MS Pharma Saudi,
Riyadh, Kingdome Saudi Arabia.
medical-ksa@mspharma.com


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jan,2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>